Transition metal complexes based on thiophene-dithiolene ligands

The chemistry of transition metal dithiolene complexes based on thiophene-dithiolene ligands (TD) is reviewed, from the ligand synthesis and complex preparation to the molecular structure and solid state physical properties of different compounds based on them. The ligands considered are based mainly either on simple thiophene-dithiolates (α-tpdt = 2,3-thiophenedithiolate, dtpdt = 4,5-dihydro-2,3-thiophenedithiolate, and tpdt = 3,4-thiophenedithiolate), or in more extended and delocalised dithiolate ligands (α-tdt = 3-({5-[(2-cyanoethyl)thio]-2-thieno[2,3-d][1,3]dithiol-2-ylidene-1,3-dithiol-4-yl}thio)propanenitrile and dtdt = 3-{5-[(2-cyanoethyl)thio]-2-(5,6-dihydrothieno[2,3-d][1,3]dithiol-2-ylidene-1,3-dithiol-4-yl)thio}propanenitrile) that besides the thiophenic ring also incorporates a fused TTF moiety. Dithiolene complexes based on ligands containing appended thiophenic units will also be briefly considered. The structural variability of these complexes that in addition to the usual square planar coordination geometry, M(TD)₂, can also present dimeric, [M(TD)₂]₂, or cluster structures such as [Cu₄(TD)₃] and [Ni₄(TD)₆], is addressed. The role of the thiophene group and its ability to enhance electronic delocalisation from the metal dithiolene core throughout the ligand and to establish solid state networks of S?S interactions is discussed. The importance of these complexes as useful building blocks to prepare molecular materials with very interesting magnetic and transport properties, ranging from metamagnets to Single Component Molecular Metals, is illustrated by different compounds based on them.     

Mixed ligand complexes of tungsten(VI) containing aroyl hydrazones and isothiocyanate

Five complexes [WO(NCS)₄L–L] (where L–L = benzoic acid[1-(Furan-2-yl)methylene]hydrazide(BFMH), benzoic acid[(thiophen-2-yl)methylene]hydrazide(BTMH), benzoic acid[1-(thiophen-2-yl)ethylidene]hydrazide(BTEH), benzoic acid(phenylmethylene)hydrazide(BPMH) and benzoic acid[1-(anisol-3-yl) methylene]hydrazide(BAMH)) have been prepared by reaction of ammonium tetraisothiocyanatodioxotungstate(VI) with the corresponding ligand in aqueous medium in the presence of hydrochloric acid. The complexes have been characterized by elemental analysis, molar conductivity, magnetic moment measurements, IR, electronic spectra, thermogravimetric analysis TGA/DTA and ¹H NMR.     

Nuclease activity of mixed ligand complexes of copper(II) with heteroaromatic derivatives and picoline

New picoline adducts with carbamic acid [(furan-2-yl)methylene]hydrazide–Cu^II (CFMH) (1); thiocarbamic acid [(furan-2-yl)methylene]hydrazide–Cu^II (TFMH) (2); carbamic acid [(furan-2-yl)ethylidene]hydrazide–Cu^II (CFEH) (3), thiocarbamic acid [(furan-2-yl)ethylidene]hydrazide–Cu^II (TFEH) (4); carbamic acid [(thiophene-2-yl) methylene]hydrazide–Cu^II (CTMH) (5), thiocarbamic acid [(thiophene-2-yl)methylene]hydrazide–Cu^II (TTMH) (6), carbamic acid [(thiophene-2-yl)ethylidene]hydrazide–Cu^II (CTEH) (7), thiocarbamic acid [(thiophene-2-yl)ethylidene]hydrazide–Cu^II (TTEH) (8) have been prepared and characterized by analytical, i.r., electronic, e.s.r. and c.v. spectral data. The electronic spectra suggest distorted octahedral geometry for all the picoline adducts. E.s.r. g values lie between 2.251–2.286 at l.n.t. All the adducts undergo a quasi-reversible one-electron reduction in the range +0.47 to +0.51 V versus s.c.e., attributable to the Cu^III/Cu^II redox couple. The electron transfer is much faster in the semicarbazone complexes than in the thiosemicarbazone complexes. All adducts showed increased nuclease activity in the presence of oxidant; the nuclease activity is compared with that of the parent copper(II) complexes.     

Syntheses and structures of lanthanide(III) complexes with some bis(pyrazolyl)borate and tris(pyrazolyl)borate podand ligands

Two new poly(pyrazolyl)borate ligands have been prepared: potassium tris[3-{(4-^tbutyl)-pyrid-2-yl}-pyrazol-1-yl]hydroborate (KTp^BuPy) which has three bidentate arms and is therefore hexadentate; and potassium bis[3-(2-pyridyl)-5-(methoxymethyl)pyrazol-1-yl]-dihydroborate (KBp^(COC)Py) which has two bidentate arms and is therefore tetradentate. The crystal structures of their lanthanide complexes [La(Tp^BuPy)(NO₃)₂] and [La(Bp^(COC)Py)₂X] (X=nitrate or triflate) have been determined. In [La(Tp^BuPy)(NO₃)₂] the metal ion is ten-coordinate, from the hexadentate N-donor podand ligand and two bidentate nitrates. [La(Bp^(COC)Py)₂(NO₃)] is also ten-coordinate, from two tetradentate ligands and a bidentate nitrate, but in [La(Bp^(COC)Py)₂(CF₃SO₃)] the metal ion is nine-coordinate because the triflate anion is monodentate. Two unexpected new complexes which arose from partial decomposition of the poly(pyrazolyl)borate ligands have also been characterised structurally. In [La(^BuPypzH)₃(O₃SCF₃)₃] the metal ion is nine-coordinate from three bidentate pyrazolyl-pyridine arms (liberated by decomposition of KTp^BuPy) and three triflate anions; there is extensive NH· · · O hydrogen-bonding between the pyrazolyl and triflate ligands. [Nd(Tp^Py)(Bp^Py)][Nd(PypzH)(NO₃)₄] was isolated from the reaction of hexadentate tris[3-(2-pyridyl)-pyrazol-1-yl]hydroborate (Tp^Py) with Nd(NO₃)₃. One of the Tp^Py ligands has lost one bidentate pyrazolyl-pyridine ‘arm’ (PypzH) to leave tetradentate tris[3-(2-pyridyl)-pyrazol-1-yl]dihydroborate (Bp^Py). In this structure, the cation [Nd(Tp^Py)(Bp^Py)]⁺ is ten-coordinate from inter-leaved hexadentate and tetradentate ligands, and the anion [Nd(PypzH)(NO₃)₄]⁻ is also ten-coordinate from the bidentate N-donor ligand PypzH and four bidentate nitrates.     

Synthesis and catalytic properties of cationic palladium(II) and rhodium(I) complexes bearing diphosphinidinecyclobutene ligands

Cationic palladium(II) and rhodium(I) complexes bearing 1,2-diaryl-3,4-bis[(2,4,6-tri-t-butylphenyl)phosphinidene]cyclobutene ligands (DPCB–Y) were prepared and their structures and catalytic activity were examined (aryl = phenyl (DPCB), 4-methoxyphenyl (DPCB–OMe), 4-(trifluoromethyl)phenyl (DPCB–CF₃)). The palladium complexes [Pd(MeCN)₂(DPCB–Y)]X₂ (X = OTf, BF₄, BAr₄ (Ar = 3,5-bis(trifluoromethyl)phenyl)) were prepared by the reactions of DPCB–Y with [Pd(MeCN)₄]X₂, which were generated from Pd(OAc)₂ and HX in MeCN. On the other hand, the rhodium complexes [Rh(MeCN)₂(DPCB–Y)]OTf were prepared by the treatment of [Rh(μ-Cl)(cyclooctene)₂]₂ with DPCB–Y in CH₂Cl₂, followed by treatment with AgOTf in the presence of MeCN. The cationic complexes catalyzed conjugate addition of benzyl carbamate to α,β-unsaturated ketones.     

Hemilability of 2-(1H-imidazol-2-yl)pyridine and 2-(oxazol-2-yl)pyridine ligands: Imidazole and oxazole ring Lewis basicity,Ni(II)/Pd(II) complex structures and spectra

Fourteen new organic molecules A1–A4, B1–B5, C1–C4 and D and a series of transition metal(II) complexes (Ni1–Ni9 and Pd1–Pd2b) were synthesized and studied in order to characterize the hemilability of 2-(1H-imidazol-2-yl)pyridine and 2-(oxazol-2-yl)pyridine ligands (A1–A4 = 2-R²-6-(4,5-diphenyl-1R¹-imidazol-2-yl)pyridines, R¹ = H or CH₃, R² = H or CH₃; B1–B5 = 1-R²-2-(pyridin-2-yl)-1R¹-phenanthro[9,10-d]imidazoles/oxazoles, R¹ = H or CH₃, R² = H or CH₃; C1–C4 = 2-(6-R²-pyridin-2-yl)-1H-imidazo/oxazo[4,5-f][1,10]phenanthrolines, R² = H or CH₃; D = 2-mesityl-1H-imidazo[4,5-f][1,10]phenanthroline). They were also used to study the substituent effects on the donor strengths as well as the coordination chemistries of the imidazole/oxazole fragments of the hemilabile ligands.All the observed protonation–deprotonation processes found within pH 1–14 media pertain to the imidazole or oxazole rings rather than the pyridyl Lewis bases. The donor characteristics of the imidazole/oxazole ring can be estimated by spectroscopic methods regardless of the presence of other strong N donor fragments. The oxazoles possessed notably lower donor strengths than the imidazoles. The electron-withdrawing influence and capacity to hinder the azole base donor strength of 4,5-azole substituents were found to be in the order phenanthrenyl (B series) > 4,5-diphenyl (A series) > phenanthrolinyl (C series). An X-ray structure of Ni5b gave evidence for solvent induced ligand reconstitution while the structure of Pd2b provided evidence for solvent induced metal–ligand bond disconnection.Interestingly, alkylation of 1H-imidazoles did not necessarily produce the anticipated push of electron density to the donor nitrogen. Furthermore, substituents on the 4,5-carbons of the azole ring were more important for tuning donor strength of the azole base. DFT calculations were employed to investigate the observed trends. It is believed that the information provided on substituent effects and trends in this family of ligands will be useful in the rational design and synthesis of desired azole-containing chelate ligands, tuning of donor properties and application of this family of ligands in inorganic architectural designs, template-directed coordination polymer preparations, mixed-ligand inorganic self-assemblies, etc.     

Mononuclear and one-dimensional manganese(II) complexes constructed by dithioethers: Effect of flexibility and positional isomerism

Interactions of dithioether ligands L², L⁴ and L⁵ (L² = 1,3-bis(4-(3-pyridyl) pyrimidin-2-ylthio) propane; L⁴ = 1,3-bis[4-(3-pyridyl) pyrimidinyl thiomethyl]benzene; L⁵ = 1,4-bis[4-(3-pyridyl)pyrimidinylthiomethyl] benzene) with Mn(II) ions and NH₄SCN in an analogous way led to the formation of two discrete mononuclear complexes and a one-dimensional chain, respectively, which may be attributed to the different flexibility and positional isomerism of the ligands.     

Synthesis and spectral studies on heterobimetallic complexes of manganese and ruthenium derived from bis[N-(2-hydroxynaphthalen-1-yl)methylene]oxaloyldihydrazide

The complex [Mn(L)(H₂O)₂] [H₄L = bis[N-(2-hydroxynaphthalen-1-yl)methylene]-oxaloyldihydrazide] reacts with activated ruthenium(III) chloride in methanol in 1:1.2 M ratio under reflux resulting in heterobimetallic complex of the composition [Mn(L)(H₂O)₄RuCl₂]Cl. The complexes of the composition [Mn(L)(A)₄RuCl₂]Cl were obtained when the above reaction was carried out in presence of heterocyclic nitrogen bases(A) such as pyridine(py), 3-picoline(3-pic) and 4-picoline(4-pic). The molar conductance values for these complexes in DMF(N,N-dimethyl formamide) solution indicate their 1:1 electrolytic nature. Magnetic moment values suggest that these heterobimetallic complexes contain Mn(IV) and Ru(III) in the same structural unit. Electronic spectral studies suggest six coordinated metal ions in these complexes. IR spectra reveal that the H₄L ligand coordinates in its keto-form to Mn(IV) and Ru(III).     

Spin-crossover in dimeric hydrogen-bonded iron(II) 2-(pyrazolyl)-pyridine and 2-(imidazolyl)-pyridine complexes

Five new hydrogen-bonded solvated iron(II) complexes of pyrazolyl- and imidazolyl-based N,N-chelating ligands have been synthesised. Water to ligand-NH hydrogen-bonded bridges occur in the pseudo-dimeric complexes {cis-[Fe(pypzH)₂(NCX)₂]₂(μ-OH₂)(H₂O)₂} · H₂O · MeOH (where X = S or Se), and in the chain complex {cis-[Fe(pypzH)₂(NCS)₂](μ-OH₂)}_n. A “half” spin-crossover (T_c = 125 K) was observed in the dimeric X = Se complex by means of magnetic measurements and no thermal hysteresis occurred between 4 and 300 K. The crystal structure at 123 K showed Fe–N distances consistent with the magnetism. Each Fe in the dimeric unit was structurally equivalent in the HS–LS state. Removal of the solvate molecules led to HS–HS behaviour over the temperature range 4–300 K. The pseudo-dimer with X = S also showed HS–HS behaviour as did the monomeric analogue cis-[Fe(pypzH)₂(NCS)₂]H₂O and a structurally different methanol-bridged dimer {cis-[Fe(pyimH)₂(NCS)₂]₂(μ-MeOH)₂} · 2MeOH (pypzH = 2-(1H-pyrazol-3-yl)-pyridine; pyimH = 2-(1H-imidazol-2-yl)-pyridine).     

Synthesis,characterization and antibacterial activity of some new triphenyltin(IV) sulfanylcarboxylates: Crystal structure of [(SnPh3)2(p-mpspa)], [(SnPh3)2(cpa)] and [(SnPh3)2(tspa)(DMSO)]

Five new triphenyltin(IV) sulfanylcarboxylates of the general formula [(SnPh₃)₂L] (L = pspa, tspa, fspa, p-mpspa or cpa, where p = 3-(2-phenyl)-, t = 3-(2-thienyl)-, f = 3-(2-furyl)-, p-mp = 3-(4-methoxyphenyl)-, spa = 2-sulfanylpropenoato and cpa = 2-cyclopentilyden-2-sulfanylacetate) have been synthesized by reacting triphenyltin(IV) hydroxide with the corresponding acid in ethanol/acetone. The complexes have been characterized by elemental analysis and mass spectrometry and by vibrational and NMR (¹H, ¹³C, ¹¹⁹Sn) spectroscopies. In the case of [(SnPh₃)₂(p-mpspa)] and [(SnPh₃)₂(cpa)], X-ray structural studies showed that in both compounds each Sn atom is coordinated to three phenyl C atoms and to one S or O atom of the bridge ligand L. All five complexes are active against strains of Staphylococcus aureus, but are inactive against Escherichia coli and Pseudomonas aeruginosa. From a solution of [(SnPh₃)₂(tspa)] in DMSO-d₆ the new complex [(SnPh₃)₂(tspa)(DMSO)] was isolated. The single-crystal X-ray diffractometric study of this complex is also reported, showing that both Sn atoms are bridged by the tspa ligand, whereas the molecule of DMSO is coordinated to one of the tin atoms via the oxygen atom.     

Theoretical investigation on homoleptic Yttrium tri-guanidinates

The electronic and molecular structures of the homoleptic Yttrium tris-guanidinates complexes Y[(NⁱPr)₂CNR₁R₂]₃, [R₁ = R₂ = Me, Et and iPr] have been investigated employing DFT calculations in order to understand the structures, bonding and energies of the interactions between Yttrium metal and guanidinate ligands. The effect of the substitution on nitrogen position of guanidinate in these complexes has been also investigated employing DFT and TDDFT calculations for six kinds of models obtained by alternative substitution of alkyl on nitrogen of the guanidinate ligands. The results reveal that the substitution position plays a crucial role in the geometric structure by affecting the torsion angle and the HOMO–LUMO transitions. The energy decomposition analysis indicates a majority of ionic bonding in all systems; the exception is in the M4 (Y[(N_YR)₂CN_CR₁R₂]₃; R = Et and R₁ = R₂ = H) which present a significant degree of covalency.     

Synthesis,anti-inflammatory and analgesic activity of 2-[4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid derivatives

The title compounds 3a–l have been synthesized by the reaction of thiocarbohydrazide with substituted phenoxy acetic acid to obtained substituted 1,2,4-triazoles (1). Compound 1 was treated with various substituted aromatic aldehydes which results in 4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-2H-1,2,4-triazol-3(4H)-thiones (2a–g), further 2a–g is converted to 2-[4-(substituted benzylideneamino)-5-(substituted phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid (3a–l) derivatives by the reaction with chloroacetic acid. All the newly synthesized compounds were evaluated for in vivo anti-inflammatory and analgesic activities. Among the series 2-[4-(2,4-dichlorobenzylideneamino)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid (3d), 2-[4-(4-dichlorobenzylideneamino)-5-(phenoxymethyl)-4H-1,2,4-triazol-3-yl thio] acetic acid (3e), 2-[4-(2,4-dichlorobenzylideneamino)-5-[(2,4-dichlorophenoxy)methyl]-4H-1,2,4-triazol-3-yl thio] acetic acid (3j) and 2-[5-[(2,4-dichlorophenoxy)methyl)]-4-(4-chlorobenzylideneamino)-4H-1,2,4-triazol-3-yl thio] acetic acid (3k) showed significant anti-inflammatory activity with P < 0.001 (63.4%, 62.0%, 64.1% and 62.5% edema inhibition, respectively), as compared to the standard drug diclofenac (67.0%) after third hour respectively and also compounds 3j, 3k exhibited significant analgesic activity with P < 0.001 (55.9% and 54.9% protection, respectively) and less ulcerogenic activity as compared with standard drug aspirin (57.8%).     

Synthesis,characterization and anticancer evaluation of 2-(naphthalen-1-ylmethyl/naphthalen-2-yloxymethyl)-1-[5-(substituted phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-1H-benzimidazole

In the present study o-phenylenediamine and naphtene-1-acetic acid/2-naphthoxyacetic acid were used as a starting material through a series of steps and 2-(naphthalen-1-ylmethyl/Naphthalen-2-yloxymethyl)-1H-benzimidazol-1-yl]acetohydrazide 5a, 5b were obtained. In the first series 1,3,4-oxadiazole derivatives have been synthesized from Schiff base of the corresponding hydrazide i.e. 2-[2-(naphthalen-1-ylmethyl)-1H-benzimidazol-1-yl]acetohydrazide 5a by using Chloramin-T. In the second series 1,3,4-oxadiazole has been synthesized from 2-{2-[(naphthalen-2-yloxy)methyl]-1Hbenzimidazol-1-yl}acetohydrazide 5b by using phosphorous oxychloride and aromatic acid. These compounds were evaluated by IR, NMR, Mass spectrometry, elemental analysis and finally in vitro anticancer evaluation was carried out by NCI 60 Cell screen at a single high dose (10–5 M) on various panel/cell lines. One compound 7c was found to be the most active on breast cancer cell line and compounds 4b and 7d were moderately active.     

Synthesis,characterization, bioactivities of copper complexes with N-allyl di(picolyl)amine

Four copper(II) complexes with N-allyl di(picolyl)amine were synthesized and characterized by physico-chemical and spectroscopic methods. The spectrophotometric and fluorescence titration data indicate that the [(Aldpa)Cu(L)](ClO₄)₂ (L = dppz, dione, phen) with conjugated aromatic rings as coordinated ligands can be inserted into the base stacks of DNA more deeply than the [(Aldpa)CuCl₂]. The copper(II) complexes [(Aldpa)Cu(L)](ClO₄)₂ (L = dppz, dione, phen) can inhibit the proliferation of the four cancer cells (Mcf-7, Eca-109, A549 and HeLa) with IC₅₀ 0.5–19.2 μM, which is larger than that (23.2–84.3 μM) of [(Aldpa)CuCl₂], suggesting their inhibiting activities on the four cancer cells are correlated with their DNA-binding properties. However, the selectivity of [(Aldpa)CuCl₂] to cancer cells is better than that of the other three complexes [(Aldpa)Cu(L)](ClO₄)₂, which indicates the substituents introduced on the secondary amino nitrogen atom of dpa have great contribution to the antitumor activities of these copper(II) complexes.     

Palladium(II) complex taken as a model of an antitumour agent: Synthesis and equilibrium investigation involving biologically relevant ligands

Pd(DHP)Cl₂ and Pd(DHP)(CBDCA) complexes (DHP = 1,3-diamino-2-hydroxopropane and CBDCA = 1,1-cyclobutanedicarboxylate), were synthesized and characterized by elemental analysis, IR and NMR spectral measurements. The coordination of [Pd(DHP)(H₂O)₂]²⁺ with some selected bio-relevant ligands, containing different functional groups was investigated. The ligands used are amino acids, peptides, DNA constituents and dicarboxylic acids. Stoichiometry and stability constants of the complexes formed are reported at 25 °C and 0.1 M ionic strength. The results show the formation of 1:1 complexes with amino acids and dicarboxylic acids. DNA constituents form 1:1 and 1:2 complexes. Peptides form both 1:1 complexes and the corresponding deprotonated amide species. The effect of chloride ion concentration and dioxane on the acid dissociation constants of 1,1-cyclobutane dicarboxylic acid (CBDCAH₂) and the formation constant of its complex with Pd(DHP)²⁺ was reported. The equilibrium constants for the displacement of coordinated ligands as uracil, glycine or methionine by cysteine are calculated. The results are expected to contribute to the chemistry of antitumour agents.     

New chloro and triphenylsiloxy derivatives of dioxomolybdenum(VI) chelated with pyrazolylpyridine ligands: Catalytic applications in olefin epoxidation

Dioxomolybdenum(VI) complexes of general formula [MoO₂X₂L₂] (X = Cl, OSiPh₃; L₂ = 2-(1-butyl-3-pyrazolyl)pyridine, ethyl[3-(2-pyridyl)-1-pyrazolyl]acetate) were prepared and characterised by ¹H NMR, IR and Raman spectroscopy. The assignment of the vibrational spectra was supported by ab initio calculations. A single crystal X-ray diffraction study of the complex [MoO₂Cl₂{ethyl[3-(2-pyridyl)-1-pyrazolyl]acetate}] showed that the compound is monomeric and crystallises in the tetragonal system with space group P4₁. The four complexes are active and selective catalysts for the liquid-phase epoxidation of olefins by tert-butylhydroperoxide. Selectivities to the corresponding epoxides were mostly 100% (for conversions of at least 34%) for the substrates cyclooctene, cyclododecene, 1-octene, trans-2-octene and (R)-(+)-limonene. For styrene epoxidation, the corresponding diol was also formed in significant quantities. The turnover frequencies for cyclooctene epoxidation at 55 °C were around 340 mol mol_Mo⁻¹ h⁻¹ for the chloro complexes and 160 mol mol_Mo⁻¹ h⁻¹ for the triphenylsiloxy complexes. The addition of co-solvents (1,2-dichloroethane or n-hexane) had a detrimental effect on catalytic activities. Kinetic studies for the two complexes bearing the ligand ethyl[3-(2-pyridyl)-1-pyrazolyl]acetate revealed an apparent first order dependence of the initial rate of cyclooctene conversion with respect to cyclooctene or oxidant concentration.     

The effect of bridgehead steric bulk on the ground state and intramolecular exchange processes of (μ-SCH2CR2CH2S)[Fe(CO)3][Fe(CO)2L] complexes

The flexibility of the coordination sphere in the diiron organometallic is likely an important design component in nature's electrocatalyst for proton reduction or H₂ oxidation, i.e, the active site of [FeFe]hydrogenase. A series of complexes, (μ-SCH₂CRR′CH₂S)[Fe(CO)₃][Fe(CO)₂L] with steric bulk incorporated into the μ-S-to-S linker was synthesized and the compounds were analyzed by infrared spectroscopy and cyclic voltammetry [(R/R′ = Me/Me, Et/Et, Bu/Et), (L = CO, PPh₃, IMes (1,3-bis(2,4,6-trimethylphenyl)-imidazol-2-ylidene), and IMe (1,3-dimethylimidazole-2-ylidene))]. While added steric bulk at the bridgehead carbon of the μ-SCH₂CR₂CH₂S produced little change in the ground state structures (X-ray diffraction) and electronic character for the (μ-SRS)[Fe(CO)₃]₂ complexes, monosubstitution of a CO with L produced distortions consistent with steric interference of the μ-SRS with nearby ligands as compared to the similar (μ-pdt)[Fe(CO)₃][Fe(CO)₂L] (pdt = S(CH₂)₃S). Variable temperature NMR studies have shown that the activation barrier for CO site exchange on the sterically bulky complexes decreases in a manner predicted by theory [J.W. Tye, M.B. Hall, M.Y. Darensbourg, Inorg. Chem. 45 (2006) 1552].     

Second-order non-linear optical response in LB films for the metal complexes

The complexes with long alkyl chains {[Fe(C₁₆-trz)₃](ClO₄)₂}_n (1), [Fe(C₁₅-BPT)₂(NCS)₂] (2), [Fe(C₁₆-salen)Cl] (3), [Fe(C₁₆-salmmen)Cl] (4), K[Fe(C₁₆-salen)(CN)₂] (5), K[Fe(C₁₆-salmmen)(CN)₂] (6), Na[Fe(C₁₆-salmmen)(CN)₂] (7), [Mn(C₁₆-salen)Cl] (8), [Ni(C₁₆-salen)] (9), [Cu(C₁₆-salen)] (10) were synthesized (C₁₆-trz = 4-hexadecyl-1,2,4-triazole, C₁₅-BPT = N-(3,5-di-2-pyridinyl-4H-1,2,4-triazol-4-yl)-hexadecanecarboxamide, C₁₆-salen = N,N-bis[4-(hexadecyloxy)salicylidene]ethylenediamine, C₁₆-salmmen = N,N′-bis[4-(hexadecyloxy)salicylidene]-1,2-diaminopropane). Langmuir–Blodgett (LB) films of compounds 1–10 were prepared (Scheme 1). The transfers of the molecules from onto the gas–water surface to glass substrate were confirmed by UV–Vis spectra. The second harmonic generation (SHG) were estimated for the LB films formed by the metal complexes. The SHG was observed for the complexes with the long alkyl chains in LB film. The order of the intensity for the SHG related with the number of unpaired d electrons or the d electron configurations.     

Thermodynamic studies on complexation of divalent transition metal ions with some zwitterionic buffers for biochemical and physiological research

The interaction between the zwitterionic buffers (3-[N-bis(2-hydroxyethyl)amino]-2-hydroxy propane sulfonic acid, N-(2-actamido)-2-aminoethane sulfonic acid, and 3-[(1,1-dimethyl-2-hydroxyethyl)amino]-2-hydroxy propane sulfonic acid) with some divalent transition metal ions (Cu^II, Ni^II, Co^II, Zn^II, and Mn^II) were studied at different temperatures (298.15 to 328.15) K at ionic strength I = 0.1 mol · dm⁻³ NaNO₃ and in the presence of 10%, 30%, and 50% (w/w) dioxene by using potentiometry. The thermodynamic stability constants were calculated as well as the free energy change for the 1:1 binary complexation. The protonation constants of the zwitterionic buffers were also determined potentiometrically under the above conditions.     

Alkyl-malonate-substituted thiacalix[4]arenes as ligands for bottom-up design of paramagnetic Gd(III)-containing colloids with low cytotoxicity

The present work introduces thiacalix[4]arene adopting 1,3-alternate conformation with alkyl-malonate terminal substituents as ligands for Gd(III) ions. pH-dependent complex formation of Gd(III) ions via alkyl-malonate substituents in aqueous DMSO solutions results in a precipitation. The precipitated complexes were converted into hydrophilic colloids of “plum-pudding” morphology, where the Gd(III) complexes form hard small (1.5–4 nm) cores included into larger (about 180 nm) soft PSS shells. The precipitate-to-colloid transformation is facilitated by polystyrolsulfonate (PSS) for Gd(III) complexes with thiacalix[4]arene bearing propyl-malonate groups, while the presence of PSS triggers a dissolution of the precipitated complexes for thiacalix[4]arenes with pentyl-malonate substituents. To a lesser extent the similar tendency disturbs the formation of PSS-stabilized colloids on the basis of butyl-malonate substituted thiacalix[4]arene. The PSS-stabilized colloids exhibit high longitudinal and transverse relaxivities (r₁ = 23.8 and r₂ = 29.4 mM⁻¹ s⁻¹ at 0.47 T, respectively), while the recoating of the PSS-stabilized colloids with polyethyleneimine is accompanied by the dissolution of the hard cores. High relaxivity along with low cytotoxicity of PSS-stabilized colloids indicates their applicability as contrast agents in MRI.